HIV-1 care in resource-poor settings: A view from Haiti

Lancet

Volumn 362, Issue 9388, 2003, Pages 994-995

  Mukherjee, Joia S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

DRUG COST; GOVERNMENT; HAITI; HEALTH CARE FINANCING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION PREVENTION; LOWEST INCOME GROUP; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0141763825     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14373-5     Document Type: Short Survey

References (5)

1. Shaw B. Pygmalion. 1916;Brentano, New York.
2. Marseille E., Hofmann P.B., Kahn J.G. HIV prevention before HAART in sub-Saharan Africa. Lancet. 359:2002;1851-1856.
3. Farmer P., Léandre F., Mukherjee J.S. Bull World Health Organ. 79:2001;1145-1151.
4. Gilks C., AbouZahr C., Türmen T. HAART in Haiti - evidence needed. Bull World Health Organ. 79:2001;1154-1155.
5. Fund the Fund. The current funding crisis. http://www.fundthefund.org/crisis.html (accessed July, 2003).